| Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue |
161 |
| UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high-dose chemoradiotherapy for patients with malignancy |
10 |
| Role of plasma exchange, leukocytapheresis, and plasma diafiltration in management of refractory macrophage activation syndrome |
8 |
| Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study |
6 |
| Therapeutic plasma exchange in acute liver failure |
6 |
| Treatment of acquired Thrombotic Thrombocytopenic Purpura in the US remains heterogeneous: Current and future points of clinical equipoise |
5 |
| Granulomonocytapheresis as a cell-dependent treatment option for patients with inflammatory bowel disease: Concepts and clinical features for better therapeutic outcomes |
5 |
| Therapeutic effect of double plasma molecular adsorption system and sequential half-dose plasma exchange in patients with HBV-related acute-on-chronic liver failure |
5 |
| Immunoadsorption or plasma exchange in steroid-refractory multiple sclerosis and neuromyelitis optica |
5 |
| Factors predicting peripheral blood progenitor cell mobilization in healthy donors in the era of related alternative donors: Experience from a single center |
5 |
| Real-world study: Escalating targeted lipid-lowering treatment with PCSK9-inhibitors and lipoprotein apheresis |
5 |
| In vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis |
5 |
| American council on ECP (ACE): Why now? |
5 |
| Therapeutic plasma exchange for management of heparin-induced thrombocytopenia: Results of an international practice survey |
5 |
| Poor peripheral blood stem cell mobilization affects long-term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation |
4 |
| Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant |
4 |
| Plasma exchange for heparin-induced thrombocytopenia in patients on extracorporeal circuits: A challenging case and a survey of the field |
4 |
| Risk of hypotensive reactions is increased when using partial saline replacement for therapeutic plasma exchange |
4 |
| Regional citrate anticoagulation with calcium replacement in pediatric apheresis |
3 |
| Autograft immune effector cells and survival in autologous peripheral blood hematopoietic stem cell transplantation |
3 |
| Current strategies for the management of autologous peripheral blood stem cell mobilization failures in patients with multiple myeloma |
3 |
| Comparison between intermittent and continuous leukapheresis protocols for autologous hematopoietic stem cell collections in children |
3 |
| Vascular access practices for therapeutic apheresis: Results of a survey |
3 |
| Combined heparin/acid citrate dextrose solution A anticoagulation in the Optia continuous mononuclear cell protocol for pediatric lymphocyte apheresis |
3 |
| Leukocytapheresis in nonmobilized donors for cellular therapy protocols: Evaluation of factors affecting collection efficiency of cells |
3 |
| Thrombotic thrombocytopenic purpura: A 5-year tertiary care centre experience |
3 |
| Critical updates in the 7(th) edition of the American Society for Apheresis guidelines |
3 |
| Membrane-based therapeutic plasma exchange (mTPE): Technical and clinical experience |
3 |
| Hospital-acquired anemia due to diagnostic and therapy-related blood loss in inpatients with myasthenia gravis receiving therapeutic plasma exchange |
3 |
| Efficacy of cytapheresis for remission induction and dermatological manifestations of ulcerative colitis |
3 |
| Hemostasis management and therapeutic plasma exchange: Results of a practice survey |
3 |
| Therapeutic plasma exchange as a novel treatment for severe intrahepatic cholestasis of pregnancy: Case series and mechanism of action |
3 |
| Depletion of (+) T cells for a haploidentical hematopoietic stem cell transplantation in children |
2 |
| Choosing Wisely for apheresis |
2 |
| Influence of vascular access devices upon efficiency of therapeutic plasma exchange |
2 |
| Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia |
2 |
| Mononuclear cell collection for extracorporeal photopheresis by using the off-line system: A comparative study between COBE Spectra and Spectra Optia devices |
2 |
| Excellent response to therapeutic plasma exchange in myasthenia gravis patients irrespective of antibody status |
2 |
| The establishment of in-house neurology driven therapeutic plasma exchange infrastructure in a resource-limited public hospital in Malaysia: Adopting and integrating evidenced-based health care technology through time |
2 |
| Literature review of apheresis procedures performed perioperatively in cardiac surgery for ASFA category indications |
2 |
| A case off TTP temporally associated with cocaine use: Implications for treatment of suspected DITMA |
2 |
| Efficacy and safety of granulocyte adsorption apheresis in elderly patients with ulcerative colitis |
2 |
| Membrane-filtration based plasma exchanges for atypical hemolytic uremic syndrome: Audit of efficacy and safety |
2 |
| Survival of a Jehovah's Witness with thrombotic thrombocytopenic purpura without using plasma: A case report and review of the literature |
2 |
| Predictive factors for successful peripheral blood stem cell mobilization and collection in children |
2 |
| Single-dose etoposide is an effective and safe protocol for stem cell mobilization in patients with multiple myeloma |
2 |
| Dietary citrate and plasma ionized calcium: Implications for platelet donors |
2 |
| How do people become plasma and platelet donors in a VNR context? |
2 |
| The Barcelona Hospital Clinic therapeutic apheresis database |
2 |
| The impact of preapheresis white blood cell count on autologous peripheral blood stem cell collection efficiency and HSC infusion side effect rate |
2 |
